Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$6.19 - $8.78 $12,887 - $18,279
-2,082 Reduced 4.68%
42,435 $285,000
Q1 2023

May 17, 2023

SELL
$7.8 - $10.11 $1.94 Million - $2.51 Million
-248,226 Reduced 84.79%
44,517 $393,000
Q4 2022

Feb 08, 2023

BUY
$6.26 - $9.34 $26,266 - $39,190
4,196 Added 1.45%
292,743 $2.24 Million
Q3 2022

Nov 14, 2022

BUY
$6.5 - $12.67 $89,615 - $174,681
13,787 Added 5.02%
288,547 $2.05 Million
Q2 2022

Aug 16, 2022

SELL
$6.4 - $14.73 $116,454 - $268,027
-18,196 Reduced 6.21%
274,760 $2.22 Million
Q1 2022

May 13, 2022

SELL
$10.12 - $28.9 $2.98 Million - $8.52 Million
-294,814 Reduced 50.16%
292,956 $4.07 Million
Q4 2021

Feb 16, 2022

BUY
$25.17 - $36.85 $616,866 - $903,119
24,508 Added 4.35%
587,770 $16.5 Million
Q3 2021

Nov 15, 2021

BUY
$30.02 - $39.87 $422,861 - $561,608
14,086 Added 2.56%
563,262 $19.1 Million
Q2 2021

Aug 19, 2021

BUY
$32.22 - $44.59 $3.58 Million - $4.95 Million
111,051 Added 25.35%
549,176 $22.4 Million
Q1 2021

May 17, 2021

BUY
$37.26 - $67.74 $16 Million - $29.1 Million
430,117 Added 5371.09%
438,125 $17.6 Million
Q4 2020

Feb 16, 2021

BUY
$45.01 - $65.47 $360,440 - $524,283
8,008 New
8,008 $473,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.